title: Tobacco cessation in 2013: what every clinician should know.
abstract: Given the many deaths caused by smoking, clinicians should offer evidence-based treatment to every patient who uses tobacco. This commentary discusses health system changes that promote treatment for tobacco use, new protocols for tobacco cessation therapies, and emerging tobacco products that are being marketed as harm-reduction tools.
authors.affiliation: Corresponding author: Dr. Adam O. Goldstein, Department of Family Medicine, University of North Carolina School of Medicine, Campus Box 7595, Manning Dr., Chapel Hill, NC 27599-7595, USA. aog@med.unc.edu.
authors.forename: Carrie
authors.initials: C
authors.lastname: Harrill-Smith
authors.forename: Carol
authors.initials: C
authors.lastname: Ripley-Moffitt
authors.forename: Adam O
authors.initials: AO
authors.lastname: Goldstein
mesh_terms: D018678:Cholinergic Agents / Q000627:therapeutic use; D002985:Clinical Protocols; D015277:Hotlines; D006801:Humans; D009657:North Carolina; D024382:Professional Role; D016540:Smoking Cessation / Q000379:methods; D020340:Tobacco Use Cessation / Q000379:methods*; D014029:Tobacco Use Disorder / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology
chemical_list: D018678:Cholinergic Agents